Raymond James & Associates’s Nuveen S&P 500 Buy-Write Income Fund BXMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.38M | Buy |
610,760
+7,661
| +1% | +$102K | 0.01% | 1324 |
|
|
2024
Q2 | $8.14M | Sell |
603,099
-12,015
| -2% | -$157K | 0.01% | 1282 |
|
|
2024
Q1 | $8.14M | Buy |
615,114
+6,135
| +1% | +$80K | 0.01% | 1278 |
|
|
2023
Q4 | $7.81M | Sell |
608,979
-989
| -0.2% | -$12.4K | 0.01% | 1258 |
|
|
2023
Q3 | $7.72M | Sell |
609,968
-53,579
| -8% | -$707K | 0.01% | 1198 |
|
|
2023
Q2 | $8.87M | Buy |
663,547
+47,539
| +8% | +$627K | 0.01% | 1128 |
|
|
2023
Q1 | $8.06M | Buy |
616,008
+35,100
| +6% | +$459K | 0.01% | 1159 |
|
|
2022
Q4 | $7.35M | Buy |
580,908
+2,140
| +0.4% | +$27.6K | 0.01% | 1178 |
|
|
2022
Q3 | $6.88M | Buy |
578,768
+64,237
| +12% | +$850K | 0.01% | 1168 |
|
|
2022
Q2 | $6.37M | Buy |
514,531
+51,780
| +11% | +$697K | 0.01% | 1245 |
|
|
2022
Q1 | $6.59M | Buy |
462,751
+182,982
| +65% | +$2.56M | 0.01% | 1304 |
|
|
2021
Q4 | $4.1M | Buy |
279,769
+10,332
| +4% | +$152K | ﹤0.01% | 1684 |
|
|
2021
Q3 | $3.83M | Buy |
269,437
+29,121
| +12% | +$427K | ﹤0.01% | 1674 |
|
|
2021
Q2 | $3.45M | Buy |
240,316
+24,447
| +11% | +$344K | ﹤0.01% | 1746 |
|
|
2021
Q1 | $2.91M | Sell |
215,869
-10,941
| -5% | -$141K | ﹤0.01% | 1776 |
|
|
2020
Q4 | $2.92M | Sell |
226,810
-10,014
| -4% | -$120K | ﹤0.01% | 1656 |
|
|
2020
Q3 | $2.67M | Sell |
236,824
-199,927
| -46% | -$2.29M | ﹤0.01% | 1577 |
|
|
2020
Q2 | $4.8M | Buy |
436,751
+14,229
| +3% | +$155K | 0.01% | 1204 |
|
|
2020
Q1 | $4.27M | Buy |
422,522
+182,446
| +76% | +$2.27M | 0.01% | 1131 |
|
|
2019
Q4 | $3.3M | Sell |
240,076
-16,130
| -6% | -$218K | ﹤0.01% | 1527 |
|
|
2019
Q3 | $3.35M | Buy |
256,206
+111
| +0% | +$1.45K | ﹤0.01% | 1478 |
|
|
2019
Q2 | $3.41M | Buy |
256,095
+8,008
| +3% | +$105K | ﹤0.01% | 1468 |
|
|
2019
Q1 | $3.27M | Buy |
248,087
+18,384
| +8% | +$238K | 0.01% | 1450 |
|
|
2018
Q4 | $2.77M | Sell |
229,703
-1,131
| -0.5% | -$14.9K | ﹤0.01% | 1443 |
|
|
2018
Q3 | $3.32M | Sell |
230,834
-10,699
| -4% | -$154K | 0.01% | 1481 |
|
|
2018
Q2 | $3.4M | Sell |
241,533
-4,958
| -2% | -$69.3K | 0.01% | 1414 |
|
|
2018
Q1 | $3.28M | Buy |
246,491
+50,020
| +25% | +$690K | 0.01% | 1398 |
|
|
2017
Q4 | $2.8M | Buy |
196,471
+22,751
| +13% | +$319K | 0.01% | 1471 |
|
|
2017
Q3 | $2.43M | Buy |
173,720
+6,089
| +4% | +$84.3K | ﹤0.01% | 1513 |
|
|
2017
Q2 | $2.32M | Buy |
167,631
+7,434
| +5% | +$103K | 0.01% | 1468 |
|
|
2017
Q1 | $2.12M | Sell |
160,197
-2,103
| -1% | -$27.7K | ﹤0.01% | 1487 |
|
|
2016
Q4 | $2.06M | Buy |
162,300
+29,222
| +22% | +$372K | 0.01% | 1472 |
|
|
2016
Q3 | $1.76M | Buy |
133,078
+55,935
| +73% | +$732K | ﹤0.01% | 1538 |
|
|
2016
Q2 | $1M | Buy |
77,143
+12,665
| +20% | +$162K | ﹤0.01% | 1733 |
|
|
2016
Q1 | $820K | Buy |
64,478
+27,745
| +76% | +$340K | ﹤0.01% | 1769 |
|
|
2015
Q4 | $493K | Buy |
36,733
+6,043
| +20% | +$77.4K | ﹤0.01% | 1992 |
|
|
2015
Q3 | $371K | Buy |
30,690
+3,689
| +14% | +$46.9K | ﹤0.01% | 2055 |
|
|
2015
Q2 | $346K | Sell |
27,001
-312
| -1% | -$4K | ﹤0.01% | 2229 |
|
|
2015
Q1 | $350K | Sell |
27,313
-4,984
| -15% | -$64.3K | ﹤0.01% | 2165 |
|
|
2014
Q4 | $391K | Buy |
+32,297
| New | +$411K | ﹤0.01% | 2042 |
|
|
2013
Q3 | – | Sell |
-117,690
| Closed | -$1.48M | – | 1910 |
|
|
2013
Q2 | $1.48M | Buy |
+117,690
| New | +$1.5M | 0.01% | 966 |
|
Other funds holding BXMX
CA
RJFSA
LC
Raymond James & Associates's BXMX Position: Q3 2024 in Review
Raymond James & Associates increased its Nuveen S&P 500 Buy-Write Income Fund (BXMX) stake by 1.3% in Q3 2024, buying an estimated $102K and bringing the position to 610,760 shares worth $8.38M. The position accounts for 0.01% of the portfolio, ranked #1324.
Raymond James & Associates first reported a position in BXMX in Q2 2013 and has held it in 41 quarters since. The position peaked at $8.87M in Q2 2023. 152 funds tracked by Wall St. Rank hold BXMX as of Q3 2024.
- Raymond James & Associates held 610,760 shares of Nuveen S&P 500 Buy-Write Income Fund worth $8.38M as of Q3 2024.
- Raymond James & Associates bought 7,661 Nuveen S&P 500 Buy-Write Income Fund shares in Q3 2024, an estimated $102K.
- Nuveen S&P 500 Buy-Write Income Fund made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1324 holding.
- Raymond James & Associates first reported a position in Nuveen S&P 500 Buy-Write Income Fund in Q2 2013 and has held it in 41 quarters since.
- Raymond James & Associates's Nuveen S&P 500 Buy-Write Income Fund position peaked at $8.87M in Q2 2023.
- 152 funds tracked by Wall St. Rank held Nuveen S&P 500 Buy-Write Income Fund as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.